Veeva Data Cloud to Deliver New Approach for Patient and Prescriber Data
Veeva to Bring Innovation, Openness, and Choice to the U.S. Market by Year End, With Other Countries to Follow
Veeva Systems announced Veeva Data Cloud to help support the industry by bringing greater innovation and choice to the data market. Veeva Data Cloud will include longitudinal patient and prescriber data offerings that will cover retail and specialty distribution channels, initially tailored for commercial use cases such as launch planning, patient segmentation, commercial analytics, AI, territory design, targeting, and incentive compensation.
Veeva to help life sciences with patient and prescriber data
Asaf Evenhaim, CEO of Crossix, is leading the development of VeevaData Cloud. Veeva Data Cloud is powered by the Crossix Data Platform, a world-class technology platform built for the development and delivery of large-scale patient data and analytics. The Crossix Data Platform combines technology, privacy-safe processes, and continually expanding health data sets. Veeva Data Cloud will have the same open and customer-friendly usage agreements that exist today with other Veevadata solutions like VeevaOpenData.
Recommended AI News: Bravo! In Tough Times, Resolute PR Firms Stand Their Ground
“The life sciences industry needs a new, modern approach to patient and prescriber data,” said Peter Gassner, founder and CEO of Veeva’s. “We aim to bring innovation and choice to the market and an open approach centered on customer success.”
Recommended AI News: The Environmental Impact of Your Favorite Movies And Shows
Veeva Data Cloud’s longitudinal patient and prescriber data solution for the U.S. market is expected to be available by December 2020 and will focus primarily on specialty distribution channels. Offerings for additional countries will follow in the coming years, enabled by a combination of Veeva product development, industry partnerships, and acquisitions.
Any expected financial impact of Veeva’s Data Cloud was incorporated into Veeva’s March 3, 2020 financial guidance and 2025 financial targets issued October 2, 2019.
Recommended AI News: 5 Technical Things you Should Know about Regression Testing and Retesting